Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-1991 | 04-1991 | 01-1991 | 10-1990 | 07-1990 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,563 | 2,529 | 2,053 | 2,058 | 2,177 |
| TOTAL | $2,563 | $2,529 | $2,053 | $2,058 | $2,177 |
| Non-Current Assets | |||||
| PPE Net | 7,632 | 7,773 | 8,099 | 8,211 | 8,232 |
| Other Non-Current Assets | 4,837 | 4,792 | 4,867 | 4,901 | 4,960 |
| TOTAL | $12,469 | $12,565 | $12,966 | $13,112 | $13,192 |
| Total Assets | $15,032 | $15,094 | $15,019 | $15,170 | $15,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,820 | 3,088 | 2,938 | 3,411 | 3,283 |
| Accrued Expenses | 3,210 | 2,471 | 2,098 | 2,743 | 2,464 |
| TOTAL | $6,619 | $6,785 | $6,942 | $7,555 | $6,826 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 736 | 721 | 706 | 690 | 675 |
| TOTAL | $2,434 | $2,395 | $2,354 | $2,595 | $2,471 |
| Total Liabilities | $9,053 | $9,180 | $9,296 | $10,150 | $9,297 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -298 | -403 | -281 | -287 | 49 |
| TOTAL | $21,380 | $22,275 | $22,397 | $22,391 | $25,727 |
| Total Liabilities And Equity | $30,433 | $31,455 | $31,693 | $32,541 | $35,024 |